Compares the effects of probiotic L67 and paraprobiotic PPL67 on inflammation in colitis mice, suggesting a safer treatment option.
Probiotics improve intestinal symptoms and reduce damage in patients with inflammatory bowel disease (IBD). However, live bacteria are not consistently effective for IBD patients because of their weaker immune system and damaged intestinal epithelial cells. This study compared the suppression effect of probiotic (L67) and paraprobiotic Lactiplantibacillus plantarum L67 (PPL67) cells on dextran sulphate sodium (DSS)‐treated Institute of Cancer Research mice. The results showed that the administration of PPL67 to DSS‐treated mice mitigated the symptoms of colitis as evidenced by reductions in DAI define levels and the pro‐inflammatory factors. So, these results indicate that L. plantarum L67 may prevent the pathogenesis of chronic colitis in a safer and more stable way.
No takes yet. Share an insight, caveat, or question.
Song et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: